Sirtris Pharmaceuticals, Inc. is a biotechnology company based in Cambridge, MA, specializing in the development of innovative therapeutics aimed at treating age-related diseases. The company focuses on harnessing the potential of sirtuins, a class of proteins involved in cellular regulation and metabolism, to create novel treatments that target metabolic disorders and other conditions associated with aging. Sirtris is committed to advancing scientific understanding and improving patient outcomes through its research and development efforts.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

14 Patents

#182 in Cambridge, MA

#1,362 in Massachusetts

#22,319 in US

#42,249 in the World

Cambridge, MA, United States of America

Sirtris Pharmaceuticals, Inc.

Forward Citations = 372

20 inventors:

Chi B Vu (12 out of 43 patents)

Pui Yee Ng (11 out of 79 patents)

Jeremy S Disch (11 out of 18 patents)

4. Jean E Bemis (11 out of 51 patents)

5. Jill C Milne (9 out of 37 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Sirtris Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/sirtris-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

5 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]